NORWALK, Conn.--(BUSINESS WIRE)--IMS Health (NYSE: RX), the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced that the 2006 global pharmaceutical market* (see endnote) grew 7.0 percent, at constant exchange rates, to $643 billion. A rebound in growth to 8.3 percent in the U.S. — fueled by an increase in prescribing volume due to Medicare Part D — and innovations in oncologics that drove strong 20.5 percent global growth in that therapeutic class, were key contributors to the market’s expansion.
